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Ferric pyrophosphate is a water-insoluble Fe compound used to fortify infant cereals and chocolate-drink powders as it causes no orga-
noleptic changes to the food vehicle. However, it is only of low absorption in man. Recently, an innovative ferric pyrophosphate has been
developed (Sunactive Fee) based on small-particle-size ferric pyrophosphate (average size 0·3mm) mixed with emulsifiers, so that it
remains in suspension in liquid products. The aim of the present studies was to compare Fe absorption of micronised, dispersible
ferric pyrophosphate (Sunactive Fee) with that of ferrous sulfate in an infant cereal and a yoghurt drink. Two separate Fe absorption
studies were made in adult women (ten women/study). Fe absorption was based on the erythrocyte incorporation of stable isotopes
(57Fe and 58Fe) 14 d after the intake of labelled test meals of infant cereal (study 1) or yoghurt drink (study 2). Each test meal was fortified
with 5 mg Fe as ferrous sulfate or micronised, dispersible ferric pyrophosphate. Results are presented as geometric means. There was no
statistically significant difference between Fe absorption from micronised, dispersible ferric pyrophosphate- and ferrous sulfate-fortified
infant cereal (3·4 and 4·1 % respectively; P¼0·24) and yoghurt drink (3·9 and 4·2 % respectively; P¼0·72). The results of the present
studies show that micronised, dispersible ferric pyrophosphate is as well absorbed as ferrous sulfate in adults. The high relative Fe bio-
availability of micronised, dispersible ferric pyrophosphate indicates the potential usefulness of this compound for food fortification.
Iron absorption: Iron fortification: Ferric pyrophosphate: Sunactive Fee
Food fortification programmes are usually considered the
most cost-effective and sustainable approach to combat
Fe deficiency. However, the success of an Fe fortification
programme depends largely on the careful choice of the
Fe compound (Hurrell, 1997, 1998). A cheap and highly
bioavailable Fe compound that causes no organoleptic
changes would be the ideal fortification compound.
Unfortunately, the water-soluble compounds, which are
the most bioavailable, for example, ferrous sulfate, often
cause unacceptable colour or flavour changes in the food
vehicle (Hurrell & Cook, 1990). Ferric pyrophosphate is
a water-insoluble Fe compound often used by European
food companies to fortify infant cereals and chocolate-
drink powders. Its main advantage is that it causes no
adverse colour and flavour changes to food vehicles.
However, it is only poorly soluble in dilute acid, such as
the gastric juice, and is thus only of mediocre absorption
in man. Human studies have reported absorption values
between 15 and 75 % relative to ferrous sulfate, depending
on batch and processing (Hurrell et al. 1989, 1991,
2000). A further disadvantage of ferric pyrophosphate
is that it cannot be used to fortify liquid products due to
its water insolubility.
Recently, a micronised, dispersible ferric pyrophosphate
has been developed for food fortification. This innovative
compound (Sunactive Fee; Taiyo Kagaku (Yokkaichi,
Japan) is produced from ferric chloride and sodium pyro-
phosphate using a dispersion technique resulting in ferric
pyrophosphate particles of very small average size (approxi-
mately 0·3mm). Further, the formation of agglomerates is
avoided by adding emulsifiers. This has the additional
advantage that the micronised ferric pyrophosphate is dis-
persible in aqueous solutions and can be used to fortify
liquid foods or drinks such as milk. Micronised, dispersible
ferric pyrophosphate has been reported to have a similar
bioavailability as ferrous sulfate in rat Hb repletion studies
(Juneja et al. 2003).
The aim of the present study was to compare Fe absorp-
tion from micronised, dispersible ferric pyrophosphate
(Sunactive Fee) with ferrous sulfate. Fe absorption was
measured in healthy women from a wheat-based infant
cereal and a yoghurt drink by using a stable-isotope
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technique based on the incorporation of Fe stable isotopes
into erythrocytes 14 d after administration.
Subjects and methods
Subjects
Twenty apparently healthy adult women (20–30 years;
maximum body weight 60 kg) were recruited from the stu-
dent and staff population at the Swiss Federal Institute of
Technology Zurich and the University of Zurich. The sub-
jects were randomly allocated into two separate studies (ten
subjects/study). Exclusion criteria included pregnancy or
lactation and known gastrointestinal or metabolic disorders.
No medication (except oral contraceptives) or vitamin and
mineral supplements were allowed during the study.
Women regularly taking vitamin and mineral supplements
discontinued the supplementation 2 weeks before the start
of the study.
The study protocol was reviewed and approved by the
ethical committee at the Swiss Federal Institute of Tech-
nology Zurich, Switzerland. Subjects were informed
orally and in writing about the aims and procedures of
the study. Written informed consent was obtained from
all study subjects.
Study design
Fe absorption was based on erythrocyte incorporation of Fe
stable-isotope labels 14 d after the intake of labelled test
meals. The Fe compounds were labelled with 57Fe or
58Fe and added to the different test meals as described
later. All test meals were fed, after an overnight fast, on
two consecutive days under strictly standardised conditions
and close supervision. A crossover study design was used
with each woman acting as her own control. On the day
before the intake of the first test meal (day 0), a venous
blood sample was drawn after an overnight fast for the
determination of Fe status parameters (Hb, and plasma fer-
ritin) and body weight and height were measured. The two
test meals were fed on the following days (days 1 and 2)
between 07.00 and 09.00 hours. No intake of food or
fluids was allowed for 3 h after the test-meal intake.
A second venous blood sample was drawn 14 d after the
intake of the second test meal (day 16).
Test meals
The test meals in study 1 consisted of 50 g roller-dried
wheat-based infant cereal (Nestle´ PTC, Orbe, Switzerland)
fed with reconstituted milk (8 g Sano Lait milk powder;
Coop Schweiz, Basel, Switzerland, and 75 ml deionised
water). The infant cereal was made from 79·7 % partially
hydrolysed wheat flour, 10 % sucrose, 4 % honey, 3 %
palm oil, 0·3 % calcium carbonate and 3 % water. Except
for Ca, no minerals or vitamins were added. The test
meals in study 2 consisted of a yoghurt drink made from
170 g unskimmed yoghurt (Joghurt Nature 3·5 % fat;
Migros Bio, Zurich, Switzerland) and 100 g unskimmed
milk (Valflora 3·8 % fat; Migros, Zurich, Switzerland).
Each test meal contained 5 mg added Fe, 4 mg Fe as
58FeSO4 plus 1 mg Fe as FeSO4 of natural isotopic compo-
sition or 5 mg Fe as micronised, dispersible [57Fe]ferric
pyrophosphate. Deionised water (200 g) was served as a
drink in study 1.
Stable isotope labels
[58Fe]ferrous sulfate was prepared from isotopically
enriched elemental Fe (Chemgas, Boulogne, France) by
dissolution in sulfuric acid and dilution to the appropriate
concentration. Micronised, dispersible [57Fe]ferric pyropho-
sphate was prepared from isotopically enriched elemental
Fe (Chemgas, Boulogne, France) by firstly dissolving the
elemental Fe in concentrated HCl. Formed 57FeCl2 was
oxidised to 57FeCl3 by the addition of H2O2 (30 %, v/v).
To remove impurities (iron oxides), the soluble 57FeCl3
was extracted into diethyl ether, followed by re-extraction
into deionised water. This FeCl3 solution was evaporated
under vacuum at 808C using a rotorvap (Rotavapor;
Buechi, Flawil, Switzerland). Thereafter, the resulting
dark red paste was crystallised to bright yellow 57FeCl3.6H2-
O. From this base compound, micronised, dispersible
[57Fe]ferric pyrophosphate was produced by Taiyo
Kagaku (Yokkaichi, Japan) by mixing 57FeCl3.6H2O,
emulsifiers (enzymically hydrolysed soya lecithin and
polyglycerol fatty acid ester) and sodium pyrophosphate
(Nanbu et al. 1998). Particle size was measured using a sub-
micron particle sizer (NiComp 370; Particle Sizing Systems,
Santa Barbara, CA, USA) and the labelled compound was
found to be equivalent to commercial Sunactive Fee with
respect to particle-size distribution (average particle size
0·24mm; Fig. 1) and visual appearance. As a comparison,
the particle-size distribution of a commercial food-grade
ferric pyrophosphate (Dr Paul Lohmann Ltd, Emmerthal,
Germany) was measured by laser light diffraction (Master-
sizer X; Malvern Instruments Ltd, Malvern, UK; Fig. 1).
Fig. 1. Particle-size distribution shown as relative volume percen-
tage frequency curve of 57Fe-labelled micronised, dispersible ferric
pyrophosphate (57Fe Sunactive Fee; Taiyo Kagaku, Yokkaichi,
Japan) (-W-). For comparison, the particle-size distribution of com-
mercial micronised, dispersible ferric pyrophosphate (Sunactive
Fee; Taiyo Kagaku, Yokkaichi, Japan) (-B-) and commercial ferric
pyrophosphate (Dr Paul Lohmann Ltd, Emmerthal, Germany) (-O-)
are shown. Particle-size distribution was measured by laser diffrac-
tion (NiComp 370; Particle Sizing Systems, Santa Barbara, CA,
USA and Mastersizer X; Malvern Instruments Ltd, Malvern, UK).
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Quantification of iron isotopes in labelled iron fortificants
Isotope-dilution MS was used to determine the concen-
tration of 57Fe and 58Fe stable isotopes in the micronised,
dispersible ferric pyrophosphate and ferrous sulfate sol-
utions. An accurately measured amount of Fe of natural
isotopic composition was added to samples taken from
the prepared solutions of labelled Fe fortificants. The Fe
standard was prepared gravimetrically from an isotopic
reference material (IRMM-014; EU Institute of Reference
Materials, Geel, Belgium). Isotopic analysis was performed
using negative thermal ionisation MS (Walczyk, 1997).
Fe concentrations in each labelled Fe fortificant solution
were calculated based on the shift in Fe isotopic abun-
dances, the determined isotopic abundances of the pure
isotopic labels and the natural Fe isotopic abundances
(Walczyk et al. 1997).
Iron status measurements
Venous blood samples (7 ml) were drawn in EDTA-treated
tubes at each sampling. Samples were analysed for Fe status
indices (Hb, plasma ferritin) and for the incorporation of
57Fe and 58Fe into erythrocytes (day 16). Whole blood
samples were portioned for the analysis of Hb and isotopic
composition and plasma was separated, sampled and frozen
for the later analysis of plasma ferritin. Hb was measured by
the cyanmethaemoglobin method (Sigma kit; Sigma, St
Louis, MO, USA) and plasma ferritin by ELISA (Ramco
Laboratories, Houston, TX, USA). Commercial quality-
control materials (DiaMed, Cressier sur Morat, Switzerland
and Ramco Laboratories, Houston, TX, USA) were ana-
lysed together with the samples analysed for Hb and
plasma ferritin respectively.
Quantification of iron isotope in blood
Each isotopically enriched blood sample was analysed in
duplicate for its Fe isotopic composition as previously
described by Walczyk et al. (1997). The blood samples
were mineralised by microwave digestion using a mixture
of HNO3 and H2O2. Fe was separated from the matrix
by anion-exchange chromatography and a solvent–solvent
extraction step into diethyl ether. Isotopic analyses were
performed by negative thermal ionisation MS (Walczyk,
1997).
Calculation of iron absorption
The amounts of 57Fe and 58Fe isotopic labels in blood 14 d
after the test-meal administrations were calculated based
on the shift in Fe isotope ratios and on the amount of Fe
circulating in the body. The calculations were based on
the principles of isotope dilution and took into account
that the Fe isotopic labels were not monoisotopic (Walczyk
et al. 1997). Circulating Fe was calculated based on blood
volume and Hb concentration (Kastenmayer et al. 1994).
Blood volume calculations were based on height and
weight according to Brown et al. (1962). For calculations
of fractional Fe absorption, 80 % incorporation of the
absorbed Fe into erythrocytes was assumed (Hosein et al.
1967).
Food analysis
All test-meal components (infant cereal and milk powder,
milk and yoghurt) were analysed for Fe and Ca by electro-
thermal–flame atomic absorption spectroscopy (SpectrAA
400; Varian, Mulgrave, Australia) after mineralisation by
microwave digestion (MLS-Ethos plus; Mikrowellen-
Labor-Systeme, Leutkirch, Switzerland) in a HNO3–
H2O2 mixture, using a standard addition technique to mini-
mise matrix effects. Phytic acid in the infant cereal was
determined by a modification of the Makower method
(Makower, 1970) in which Ce replaced Fe in the precipi-
tation step.
Statistics
Fractional Fe absorption values are presented as geometric
means and standard deviations (21 SD, þ1 SD). Student’s
paired t test was used to evaluate absorption data within
each study. Absorption values were logarithmically trans-
formed before statistical analysis (Excel 2002; Microsoft
Corporation, Redmond, WA, USA).
Results
None of the subjects were found to be anaemic
(Hb,120 g/l). However, nine women had no Fe stores
indicated by low plasma ferritin values (,12mg/l).
The test meals in study 1 (infant cereal) contained
0·6 mg Fe (1·1 mg Fe/100 infant cereal, 0·15 mg Fe/100 g
milk powder), 167 mg Ca (148 mg Ca/100 g infant cereal,
1159 mg Ca/100 g milk powder) and 84 mg phytic acid
(168 mg phytic acid/100 g infant cereal). The yoghurt
drink served in study 2 contained 0·06 mg Fe (23mg
Fe/100 g unskimmed milk, 22mg Fe/100 g unskimmed
yoghurt), and 340 mg Ca (109 mg Ca/100 g unskimmed
milk, 137 mg Ca/100 g unskimmed yoghurt). The ascorbic
acid content was not measured as it was assumed to be
negligible in both test meals.
There was no statistically significant difference between
Fe absorption from the micronised, dispersible ferric pyro-
phosphate- and the ferrous sulfate-fortified infant cereal
(geometric mean 3·4 and 4·1 % respectively; P¼0·24)
(Table 1). There was also no statistically significant differ-
ence between Fe absorption from the micronised, dispersi-
ble ferric pyrophosphate- and the ferrous sulfate-fortified
yoghurt drink (geometric mean 3·9 and 4·2 % respectively;
P¼0·72) (Table 2).
Discussion
When measuring Fe absorption from Fe fortification com-
pounds using stable or radioisotope techniques it is extre-
mely important that the physical and chemical properties
of the labelled compounds are comparable with those of
their commercial counterpart. In the case of ferrous sulfate,
it is relatively easy to prepare a labelled compound with
physical and chemical properties similar to commercially
available ferrous sulfate. The production of labelled micron-
ised, dispersible ferric pyrophosphate was however more
complex. This was mainly due to the necessity to synthesise
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ferric trichloride in the hexahydrate form from isotopically
enriched metal, free of acid residues and iron oxides. The
labelled micronised, dispersible ferric pyrophosphate was
made using a down-scaled manufacturing procedure similar
to the commercial production procedure and the resulting
compound was found to have a similar particle-size distri-
bution as the commercial compound (Fig. 1).
The results of the present studies showed that micro-
nised, dispersible ferric pyrophosphate is as well absorbed
as ferrous sulfate from a wheat-based infant cereal as well
as from a yoghurt drink. In previous studies with adult sub-
jects, ferric pyrophosphate has been reported to have a
relative bioavailability (RBV) compared with ferrous sul-
fate (RBV 100 %) varying from 15 to 75 %. In infant
cereals, the values reported were between 15 and 39 %
(Hurrell et al. 1989, 1991, 2000). The high RBV of Fe
from micronised, dispersible ferric pyrophosphate, as
demonstrated in the present study, is probably related to
the extremely small particle size of the Fe compound
which is approximately twenty times smaller than regular
ferric pyrophosphate (average particle size 7·5mm;
Fig. 1). In rat studies, decreasing the particle size of
water-insoluble Fe compounds has previously been
shown to have a positive influence on Fe absorption.
Shah & Belonje (1973), for example, showed that the
RBV of electrolytic Fe powder increased from 12 to
32 % when the proportion of particles below 10mm was
increased from 62 to 99 %. Further, Motzok et al. (1975)
demonstrated that decreasing particle size of CO-reduced
Fe powders from 24–40mm to 7–10mm increased RBV
from 11 to 31 %. Fe absorption from ferric orthophosphate
has also been shown to be dependent on particle size as
Table 1. Iron absorption by ten healthy adult women from infant cereal (study 1) fortified with ferrous sulfate or micronised, dispersible ferric
pyrophosphate (Sunactive Fee*) (5 mg iron/meal)
Fe absorption (%)
Plasma ferritin (mg/l) Hb (g/l)
Micronised, dispersible
ferric pyrophosphate
Ferrous
sulfate Relative bioavailability (%)†
Subject no.
1 6·9 129 4·5 8·7 52
2 11·0 136 1·8 2·4 75
3 19·8 130 3·1 4·4 70
4 56·5 140 1·5 1·9 78
5 15·8 149 3·3 5·4 61
6 9·1 127 3·4 1·8 187
7 11·8 142 4·4 8·0 55
8 11·9 138 6·4 3·1 205
9 20·8 150 2·4 3·3 72
10 7·4 132 6·9 9·3 75
Geometric mean 3·4 4·1 83
2SD 2·2 2·2 51
þSD 5·6 7·6 133
* Taiyo Kagaku, Yokkaichi, Japan.
† Fe absorption from ferrous sulfate ¼ 100 %.
Table 2. Iron absorption by ten healthy adult women from yoghurt drink (study 2) fortified with ferrous sulfate or micronised, dispersible ferric
pyrophosphate (Sunactive Fee*) (5 mg iron/meal)
Fe absorption (%)
Plasma ferritin (mg/l) Hb (g/l)
Micronised, dispersible
ferric pyrophosphate
Ferrous
sulfate Relative bioavailability (%)†
Subject no.
11 20·9 141 1·1 2·7 41
12 41·1 143 2·4 2·7 88
13 7·9 129 5·3 6·0 89
14 28·6 134 4·7 2·0 237
15 9·7 129 14·0 20·0 70
16 16·2 152 5·9 5·2 114
17 7·9 129 8·1 11·6 70
18 79·3 131 0·5 0·8 66
19 23·9 145 7·1 4·0 180
20 28·4 142 5·3 4·8 109
Geometric mean 3·9 4·2 94
2SD 1·5 1·7 56
þSD 10·5 10·3 157
* Taiyo Kagaku, Yokkaichi, Japan.
† Fe absorption from ferrous sulfate ¼ 100 %.
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RBV increased nearly 8-fold (from 6 to 46 %) when par-
ticle size was decreased from approximately 15mm to
below 1mm (Harrison et al. 1976). In human subjects,
Bjo¨rn-Rasmussen et al. (1977) reported that Fe absorption
from hydrogen-reduced elemental Fe powders was depen-
dent on their solubility in dilute acid, which in turn was
partly dependent on particle size and active surface area.
In the present study, it was not technically feasible to pro-
duce labelled ferric pyrophosphate with the same particle
size distribution as Sunactive Fee without the addition
of emulsifiers. Therefore, we were not able to evaluate if
the high RBV of micronised, dispersible ferric pyropho-
sphate was only due to the small particle size or whether
the emulsifiers influenced Fe absorption significantly.
Based on the results from the present studies, micro-
nised, dispersible ferric pyrophosphate could be a very
useful Fe fortificant, especially since it can be expected
to cause fewer organoleptic problems than water-soluble
Fe compounds. Extensive organoleptic studies, however,
still remain to be carried out. Presently, Sunactive Fee is
being used in Japan to fortify milk and milk products.
Milk products have previously been shown to be difficult
to fortify with readily absorbable Fe due to organoleptic
problems (Demott, 1971; Edmondson et al. 1971; Kurtz
et al. 1973; Wang & King, 1973). Fe fortificants that
have been shown to be suitable for fluid milk fortification
include ferric ammonium citrate, ferrous bisglycinate and
encapsulated ferrous sulfate (Edmondson et al. 1971;
Wang & King, 1973; Boccio et al. 1997; Olivares et al.
1997). While ferrous bisglycinate would be expected to
be at least as well absorbed as ferrous sulfate (Fox et al.
1998), if not better (Bovell-Benjamin et al. 2000; Layrisse
et al. 2000), ferric ammonium citrate has been reported to
be less well absorbed than ferrous sulfate (Grebe et al.
1975; Layrisse et al. 1976; Gonzalez et al. 2001).
In addition to milk products, micronised, dispersible
ferric pyrophosphate is potentially a suitable Fe fortificant
for food vehicles that are difficult to fortify with readily
available Fe such as chocolate-drink powders, cereal pro-
ducts, iodised salt, and bouillon cubes. Further, the overall
acceptability of simulated rice grains (Kapanidis & Lee,
1996) may be improved by using micronised, dispersible
ferric pyrophosphate instead of ferrous sulfate as less
discoloration of fortified rice grains can be expected.
Although not statistically different, absorption from
micronised, dispersible ferric pyrophosphate relative to fer-
rous sulfate was somewhat lower from the infant cereal
than from the yoghurt drink in the present study (Tables 1
and 2). The differences in relative Fe absorption from
different meals could be related to the differences in the
dissolution of micronised, dispersible ferric pyrophosphate
in the gastric juice as well as gastric emptying rate which
both depend on meal composition (Hallberg et al., 1986).
Further studies are needed to evaluate the RBV of micro-
nised, dispersible ferric pyrophosphate added to different
food vehicles.
In conclusion, the results of the present studies show that
Fe absorption from micronised, dispersible ferric pyropho-
sphate (Sunactive Fee) is similar to that of ferrous sulfate
from a fortified infant cereal as well as from a fortified
yoghurt drink. The high RBV is presumably due to the
very small particle size. Micronised, dispersible ferric
pyrophosphate can be expected to provoke fewer unaccep-
table sensory changes than water-soluble Fe compounds in
different food vehicles; however, comprehensive sensory
studies are now needed to fully evaluate the usefulness
of this compound.
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